基于临床病理与影像特征预测乳腺癌HER2阳性表达机器学习模型
本研究纳入2541例病理确诊的原发性乳腺病变女性患者,利用治疗前乳腺X线摄影和乳腺MRI数据及临床病理特征,采用XGBoost结合人工神经网络(ANN)和多因素逻辑回归(LR)构建预测HER2阳性表达的模型。ANN模型在训练队列、测试队列和前瞻性验证队列的AUC分别为0.853、0.821和0.809,表现优于LR模型。
要点
- XGBoost筛选的HER2阳性关键特征为肿瘤大小、可疑钙化、Ki-67指数、毛刺征和最小ADC值。
- ANN模型在训练队列AUC为0.853(95%CI 0.837-0.872),测试队列0.821(95%CI 0.798-0.853),验证队列0.809(95%CI 0.776-0.841)。
- ANN模型预测HER2阳性表达的表现持续优于LR模型。
核心结论
- 基于XGBoost算法结合RFE-CV筛选的显著特征子集构建的ANN模型在预测乳腺癌HER2阳性表达方面显示出潜力。
研究设计与样本
- 共纳入2541例连续女性患者,2034例2018年1月至2022年12月治疗者为回顾性开发队列,507例2023年1月至2024年5月治疗者为前瞻性验证队列;开发队列按8:2随机分为训练队列(n=1628)和测试队列(n=406);记录治疗前乳腺X线摄影和乳腺MRI数据及临床病理特征;采用XGBoost结合ANN和多因素LR分析提取特征并构建ANN模型和LR模型;用ROC曲线评估预测价值。
诊断标准与关键数值
- 经RFE-CV降维后,XGBoost算法识别肿瘤大小、可疑钙化、Ki-67指数、毛刺征和最小ADC值为提示乳腺癌HER2阳性表达的关键特征子集;ANN模型AUC在训练队列为0.853(95%CI 0.837-0.872),测试队列为0.821(95%CI 0.798-0.853),验证队列为0.809(95%CI 0.776-0.841)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop a machine learning (ML) model based on clinicopathological and imaging features to predict the Human Epidermal Growth Factor Receptor 2 (HER2) positive expression (HER2-p) of breast cancer (BC), and to compare its performance with that of a logistic regression (LR) model.
MATERIALS AND METHODS: A total of 2541 consecutive female patients with pathologically confirmed primary breast lesions were enrolled in this study. Based on chronological order, 2034 patients treated between January 2018 and December 2022 were designated as the retrospective development cohort, while 507 patients treated between January 2023 and May 2024 were designated as the prospective validation cohort. The patients were randomly divided into a train cohort (n=1628) and a test cohort (n=406) in an 8:2 ratio within the development cohort. Pretreatment mammography (MG) and breast MRI data, along with clinicopathological features, were recorded. Extreme Gradient Boosting (XGBoost) in combination with Artificial Neural Network (ANN) and multivariate LR analyses were employed to extract features associated with HER2 positivity in BC and to develop an ANN model (using XGBoost features) and an LR model, respectively. The predictive value was assessed using a receiver operating characteristic (ROC) curve.
RESULTS: Following the application of Recursive Feature Elimination with Cross-Validation (RFE-CV) for feature dimensionality reduction, the XGBoost algorithm identified tumor size, suspicious calcifications, Ki-67 index, spiculation, and minimum apparent diffusion coefficient (minimum ADC) as key feature subsets indicative of HER2-p in BC. The constructed ANN model consistently outperformed the LR model, achieving the area under the curve (AUC) of 0.853 (95% CI: 0.837-0.872) in the train cohort, 0.821 (95% CI: 0.798-0.853) in the test cohort, and 0.809 (95% CI: 0.776-0.841) in the validation cohort.
CONCLUSION: The ANN model, built using the significant feature subsets identified by the XGBoost algorithm with RFE-CV, demonstrates potential in predicting HER2-p in BC.
引用
- Qin X, Yang W, Zhou X, et al. A Machine Learning Model for Predicting the HER2 Positive Expression of Breast Cancer Based on Clinicopathological and Imaging Features. Acad Radiol. 2025. PMID: 39837702. doi:10.1016/j.acra.2025.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。